Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
CorMedix Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
CRMD
Nasdaq
2834
www.cormedix.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for CorMedix Inc.
CorMedix’s (CRMD) Return to Profitability and ESOP Plan Might Change the Case For Investing
- Nov 14th, 2025 2:12 am
Talphera (TLPH) Q3 2025 Earnings Call Transcript
- Nov 13th, 2025 10:15 am
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
- Nov 12th, 2025 2:05 pm
CorMedix: Q3 Earnings Snapshot
- Nov 12th, 2025 5:38 am
CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance
- Nov 12th, 2025 5:30 am
Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus
- Nov 11th, 2025 10:52 am
Wall Street Analysts Predict an 80.58% Upside in CorMedix (CRMD): Here's What You Should Know
- Nov 10th, 2025 7:55 am
Assessing CorMedix (CRMD) Valuation After Recent Momentum Pause and Melinta Therapeutics Acquisition
- Nov 10th, 2025 6:14 am
IOVA Soars 28% on Narrower-Than-Expected Loss in Q3, Revenues Up Y/Y
- Nov 7th, 2025 11:45 am
Allogene Posts Narrower-Than-Expected Loss in Q3, Nil Sales
- Nov 7th, 2025 9:20 am
Revolution Medicines Posts Wider-Than-Expected Loss in Q3, Sales Nil
- Nov 6th, 2025 11:59 am
JAZZ Beats on Q3 Earnings & Sales, Narrows '25 Sales View
- Nov 6th, 2025 8:50 am
Viatris Tops Q3 Earnings & Revenue Estimates, Ups '25 Guidance
- Nov 6th, 2025 8:24 am
Amicus' Q3 Earnings Beat, Higher Product Sales Drive Y/Y Revenues
- Nov 5th, 2025 8:08 am
Bet on 5 Top-Ranked Stocks With Rising P/E
- Nov 5th, 2025 7:11 am
All You Need to Know About CorMedix (CRMD) Rating Upgrade to Strong Buy
- Nov 4th, 2025 10:00 am
New Strong Buy Stocks for November 4th
- Nov 4th, 2025 5:22 am
Could the FDA Approval Spark a New Chapter for CorMedix in 2025?
- Nov 3rd, 2025 12:08 am
CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025
- Oct 31st, 2025 6:30 am
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Buy?
- Oct 30th, 2025 12:05 pm
Scroll